Cellipont Bioservices and Ronawk Partner to Advance Scalable Expansion of High-Quality Mesenchymal Stem Cells and Biologics

The WOODLANDS, Texas, and OVERLAND PARK, Kan — November 19, 2025/ Cision / – Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), today announced a strategic collaboration with Ronawk, developer of the Bio-OS™ biological operating system, to accelerate the scalable expansion of high-quality mesenchymal stem cells (MSCs). The partnership addresses key